Integral Health Asset Management’s Zimmer Biomet ZBH Stock Holding History

Integral Health Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$4.52M	–	118
2026 Q1	$4.52M	Buy	+50,000	New	+$4.59M	0.22%	78
2024 Q1	–	Sell	-100,000	Closed	-$12.2M	–	96
2023 Q4	$12.2M	Buy	100,000 +30,000	+43%	+$3.35M	1.66%	23
2023 Q3	$7.86M	Sell	70,000 -230,000	-77%	-$29.2M	1.09%	38
2023 Q2	$43.7M	Buy	+300,000	New	+$40.8M	5.41%	2
2023 Q1	–	Sell	-65,000	Closed	-$8.29M	–	91
2022 Q4	$8.29M	Buy	+65,000	New	+$7.54M	1.74%	25
2022 Q3	–	Sell	-41,748	Closed	-$4.39M	–	79
2022 Q2	$4.39M	Buy	41,748 +11,748	+39%	+$1.39M	0.9%	38
2022 Q1	$3.84M	Buy	+30,000	New	+$3.62M	1%	36
2021 Q4	–	Sell	-61,800	Closed	-$8.78M	–	84
2021 Q3	$8.78M	Buy	61,800 +25,750	+71%	+$3.79M	2.52%	13
2021 Q2	$5.63M	Sell	36,050 -20,600	-36%	-$3.34M	1.55%	28
2021 Q1	$8.8M	Buy	+56,650	New	+$8.78M	2.52%	13
2020 Q4	–	Sell	-51,500	Closed	-$6.81M	–	84
2020 Q3	$6.81M	Buy	51,500 +15,450	+43%	+$2.02M	2.08%	15
2020 Q2	$4.18M	Buy	+36,050	New	+$4.15M	1.25%	34

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Integral Health Asset Management's ZBH Position: Q2 2026 in Review

Integral Health Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 50,000 shares — an estimated $4.52M sold.

Integral Health Asset Management first reported a position in ZBH in Q2 2020 and held it in 12 quarters. The position peaked at $43.7M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Integral Health Asset Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Integral Health Asset Management sold 50,000 Zimmer Biomet shares in Q2 2026, an estimated $4.52M.
Integral Health Asset Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 12 quarters.
Integral Health Asset Management's Zimmer Biomet position peaked at $43.7M in Q2 2023.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.